Manila Bulletin
AstraZeneca assures safety of its COVID-19 vaccine
AstraZeneca has reaffirmed the safety of its COVID-19 vaccine, stating there is no evidence of an increased risk of blood clots among those vaccinated.
The pharmaceutical company emphasized that vaccine safety is a top priority and that they continuously monitor its security.
A thorough review of safety data from over 17 million individuals vaccinated in the EU and UK showed no increased risk of pulmonary embolism, deep vein thrombosis (DVT), or thrombocytopenia.
The company noted that reported cases of DVT and pulmonary embolism among vaccine recipients were significantly lower than naturally occurring rates in the general population and comparable to other licensed COVID-19 vaccines.
AstraZeneca committed to making its monthly safety report public on the European Medicines Agency website as part of transparency measures.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
Presidential Adviser for Entrepreneurship Joey Concepcion stated that the business sector remains confident in the Oxford-AstraZeneca vaccine.
Read more →
The Philippines will continue its AstraZeneca COVID-19 vaccination program as the doses that arrived in the country are from a different batch than those being investigated for blood clot concerns in Europe.
+2
Read more →